Pure Global

SANSURE Novel Coronavirus (2019-nCoV) nucleic Acid Diagnostic Kit (PCR-Fluorescence) - Indonesia BPOM Medical Device Registration

SANSURE Novel Coronavirus (2019-nCoV) nucleic Acid Diagnostic Kit (PCR-Fluorescence) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303420320. The device is manufactured by SANSURE BIOTECH INC. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. SANSURE BIOTECH INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
SANSURE Novel Coronavirus (2019-nCoV) nucleic Acid Diagnostic Kit (PCR-Fluorescence)
Analysis ID: AKL 20303420320

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. SANSURE BIOTECH INDONESIA

AR Address

SANSURE BIOTECH INDONESIA

Registration Date

Aug 01, 2024

Expiry Date

Mar 05, 2029

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing